Clinical trial · Interventional
Resection for Multiple Hepatocellular Carcinomas (HCC)
Hepatic Resection for Multiple Hepatocellular Carcinoma on Cirrhosis
NCT01387061CI-TRIAL-00005509completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Surgical resection in patients with multiple hepatocellular carcinomas (HCC) remains controversial. The aim of this study was to investigate the outcome of a consecutive cohort of patients resected for multiple HCC, without macrovascular invasion, in order to identify clinically reliable parameters to select patients for surgery.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cirrhosis | — | UNRESOLVED | — |
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Multiple Tumors | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| hepatic resection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- hepatic resection
- interventionNames
- Procedure: hepatic resection
Primary outcomes (1)
- measure
- Overall survival plus multivariate analysis
- timeFrame
- 10 years
- description
- The primary endpoint of the study was the overall survival of patients resected for multiple HCC, and the univariate and multivariate analyses of prognostic factors for overall survival.
Secondary outcomes (1)
- measure
- Disease-free survival
- timeFrame
- 10 years
- description
- The secondary endpoint was the disease-free survival.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * patients with multiple HCC without macrovascular invasion on liver cirrhosis Exclusion Criteria: * macrovascular invasion; * normal liver; * distant or lymphnodes metastasis
References
Publications (0)
Data not yet available
No reference posted for this study.